[1] 曹景利, 朱学良. 上皮细胞极性的建立和维持[J]. 中国细胞生物学学报, 2010, 32(2):163168.
[2] Kemphues KJ, Priess JR, Morton DG, et al. Identification of genes required for cytoplasmic localization in early C.elegans embryos[J]. Cell, 1988, 52(3):311320.
[3] Assémat E, Bazellières E, PallesiPocachardE, et al. Polarity complex proteins[J]. BiochimBiophys Acta, 2008, 1778(3):614630.
[4] Yang Z, Xue B, UmitsuM, et al. The signaling adaptor Gab1 regulates cell polarity by acting as a PAR protein scaffold[J]. Mol Cell, 2012, 47(3):469483.
[5] Kodani A, Tonthat V, Wu B, et al. Par6 alpha interacts with the dynactin subunit p150 Glued and is a critical regulator of centrosomal protein recruitment[J]. Mol Biol Cell, 2010, 21(19):33763385.
[6] DormoyV, TormanenK, SutterlinC. Par6gamma is at the mother centriole and controls centrosomal protein composition through a Par6alphadependent pathway[J]. J Cell Sci, 2013, 126(pt3):860870.
[7] Sivasubramaniyam T, Garcia J, Tagliaferro A, et al. Where polarity meets fusion: role of Par6 in trophoblast differentiation during placental development and preeclampsia[J]. Endocrinology, 2013, 154(3):12961309.
[8] Ganem NJ, Godinho SA, Pellman D. A mechanism linking extra centrosomes to chromosomal instability[J]. Nature, 2009, 460(7252):278282.
[9] ViloriaPetit AM, WranaJL. The TGFβPar6 polarity pathway:linking the par complex to EMT and breast cancer progression[J]. Cell Cycle, 2010, 9(4):623624.
[10] GunaratneA, ThaiBL, DiGuglielmoGM. Atypical protein kinase C phosphorylates Par6 and facilitates transforming growth factor βinduced epithelialtomesenchymal transition[J]. Mol Cell Biol, 2013, 33(5):874886.
[11] GunaratneA, DiGuglielmo GM. Par6 is phosphorylated by aPKC to facilitate EMT[J]. Cell Adh Migr, 2013, 7(4):357361.
[12] Zihni C, Munro PM, Elbediwy A, et al. Dbl3 drives Cdc42 signaling at the apical margin to regulate junction position and apicaldifferentiation[J]. J Cell Biol, 2014, 204(1):111127.
[13] Bryant DM, MostovKE. From cells to organs:building polarized tissue[J]. Nat Rev Mol Cell Biol, 2008, 9(11):887901.
[14] Warner SJ, Yashiro H, Longmore GD. The cdc42/par6/apkc polarity complex regulates apoptosis induced compensatory proliferation in epithelial[J]. Curr Biol, 2010, 20(8):677686.
[15] Kim M, Datta A, Brakeman P, et al. Polarity proteins PAR6 and aPKC regulate cell death through GSK3 in 3D epithelial morphogenesis[J]. J Cell Sci, 2007, 120(pt14):23092317.
[16] AveryCooper G, Doerr M, Gilbert RW, et al. Par6 is an essential mediator of apoptotic response to transforming growth factor beta in NMuMG immortalized mammary cells[J]. Cancer Cell Int, 2014, 14(1):19.
[17] ViloriaPetit AM, David L, Jia JY, et al. A role for the TGFbetaPar6 polarity pathway in breast cancer progression[J]. Proc Natl Acad Sci USA, 2009, 106(33):1402814033.
[18] Aranda V, Nolan ME, Muthuswamy SK. Par complex in cancer: a regulator of normal cell polarity joins the dark side[J]. Oncogene, 2008, 27(55):68786887.
[19] Nolan ME, Aranda V, Lee S, et al. The polarity protein Par6 induces cell proliferation and is overexpressed in breast cancer[J]. Cancer Res, 2008, 68(20):82018209.
[20] Aranda V, Haire T, Nolan ME, et al. Par6aPKC uncouples ErbB2 induced disruption of polarizedepithelial organization from proliferation control[J]. Nat Cell Biol 2006, 8(11):12351245.
[21] MartinBelmonte F, PerezMoreno M. Epithelial cell polarity, stem cells and cancer[J]. Nat Rev Cancer, 2012, 12(1): 2338.
[22] Imamura N, Horikoshi Y, Matsuzaki T,et al. Localization of aPKC Lambda/Iota and Its Interacting Protein,Lgl2,is significantly axxociated with lung adenocarcinoma progression[J]. Tokai J ExpClin Med, 2013, 38(4):146158.
[23] Frederick LA, Matthews JA, Jamieson L, et al. Matrix metalloproteinase10 is a critical effector of protein kinase CiotaPar6alphamediated lung cancer[J]. Oncogene, 2008, 27(35):48414853.
[24] Regala RP, Thompson EA, Fields AP. Atypical Protein Kinase CιExpression and Aurothiomalate Sensitivity in Human Lung Cancer Cells[J]. Cancer Res, 2008, 68(14):58885895.
[25] Pollicino T, Vegetti A, SaittaC, et al. Hepatitis B virus DNA integration in tumour tissue of a noncirrhotic HFEhaemochromatosis patient with hepatocellular carcinoma[J]. J Hepatol, 2013, 58(1):190193.
[26] Du GS, Wang JM, Lu JX, et al. Expression of PaPKCiota, Ecadherin, and betacatenin related to invasion and metastasis in hepatocellular carcinoma[J]. Ann Surg Oncol, 2009, 16(6):15781586.
[27] Namdarian B, Wong E, GaleaR, et al. Loss of APKC expression independently predicts tumor recurrence in superficial bladder cancers[J]. Urol Oncol, 2013, 31(5):649655.
[28] Trani M, Sorrentino A, Busch C, et al. Proapoptotic effect of aurothiomalate in prostate cancer cells[J]. Cell Cycle, 2009, 8(2):306313. |